Skip to main content
OpenTrials
Completed

NCT Number: NCT00824798

Gait Evaluation in Haemophiliac Patients

Joint damage secondary to recurrent haemarthroses and chronic synovitis represents the commonest clinical manifestation of haemophilia. Incapacitating pain, loss of joint stability and mobility, axial deviation, deterioration and decreased function are the most frequent complains in patients with severe haemophilic arthropathy In this context, the purpose of our study is to examine and analyse specific changes in gait in patients suffering from haemophilic arthropathy and determine the impact on health-related quality of life in terms of conceptual components of pain and stiffness, psychosocial stress, disability, and activity limitations as recommended by the International Classification of Function (ICF) recently published by the World Health Organization.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • haemophilia A or B
  • aged more than 4 years

Exclusion criteria

  • impossibility to walk on a treadmill
  • recent joint haemarthrosis or muscle haematoma

Treatment and study plan

Primary outcomes

  1. evaluate specific changes in gait in patients suffering from haemophilic arthropathy

    Time frame: from inclusion in the study until 1 year after inclusion

Sponsors and collaborators

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other

Registry information

Acronym: GAIT_GENERAL

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Jan 19, 2009
Registry last updated
Jul 11, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.